Erbb4 Deletion from Fast-Spiking Interneurons Causes Schizophrenia-like Phenotypes

Neuron

Volumn 79, Issue 6, 2013, Pages 1152-1168

  delPino, Isabel ^a   García Frigola, Cristina ^a   Dehorter, Nathalie ^a   Brotons Mas, JorgeR ^a   Alvarez Salvado, Efrén ^a   MartínezdeLagrán, María ^b   Ciceri, Gabriele ^a   Gabaldón, MaríaVictoria ^c   Moratal, David ^c   Dierssen, Mara ^b   Canals, Santiago ^a   Marín, Oscar ^a   Rico, Beatriz ^a  

^a CSIC   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^c UNIVERSITAT POLITÈCNICA DE VALÈNCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASKET CELL; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN CORTEX SYNCHRONY; BRAIN FUNCTION; BRAIN REGION; CHANDELIER CELL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTIONAL DISORDER; ERBB4 GENE; FUNCTIONAL DISEASE; GENE DELETION; INTERNEURON; LOCOMOTION; MOUSE; NERVE CELL INHIBITION; NERVE CELL NETWORK; NERVE EXCITABILITY; NERVOUS SYSTEM PARAMETERS; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

ACTION POTENTIALS; ANIMALS; ANIMALS, NEWBORN; BRAIN; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; ELECTROPORATION; GLUTAMATE DECARBOXYLASE; GREEN FLUORESCENT PROTEINS; INTERNEURONS; LIM-HOMEODOMAIN PROTEINS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; NERVE TISSUE PROTEINS; PARVALBUMINS; PATCH-CLAMP TECHNIQUES; PHENOTYPE; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, GABA-A; SCHIZOPHRENIA; SOCIAL BEHAVIOR; STATISTICS AS TOPIC; SYNAPTIC TRANSMISSION; TRANSCRIPTION FACTORS;

EID: 84884266306     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2013.07.010     Document Type: Article

References (91)

1. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 1995, 52:258-266.
2. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
3. Brotons-Mas J.R., Montejo N., O'Mara S.M., Sánchez-Vives M.V. Stability of subicular place fields across multiple light and dark transitions. Eur. J. Neurosci. 2010, 32:648-658.
4. Buzsáki G., Draguhn A. Neuronal oscillations in cortical networks. Science 2004, 304:1926-1929.
5. Cano-Colino M., Compte A. A computational model for spatial working memory deficits in schizophrenia. Pharmacopsychiatry 2012, 45(Suppl 1):S49-S56.
6. Cardin J.A., Carlén M., Meletis K., Knoblich U., Zhang F., Deisseroth K., Tsai L.H., Moore C.I. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 2009, 459:663-667.
7. Carlén M., Meletis K., Siegle J.H., Cardin J.A., Futai K., Vierling-Claassen D., Rühlmann C., Jones S.R., Deisseroth K., Sheng M., et al. A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol. Psychiatry 2012, 17:537-548.
8. Chacón M.R., Navarro A.I., Cuesto G., del Pino I., Scott R., Morales M., Rico B. Focal adhesion kinase regulates actin nucleation and neuronal filopodia formation during axonal growth. Development 2012, 139:3200-3210.
9. Chattopadhyaya B., Di Cristo G., Wu C.Z., Knott G., Kuhlman S., Fu Y., Palmiter R.D., Huang Z.J. GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron 2007, 54:889-903.
10. Chen P.L., Avramopoulos D., Lasseter V.K., McGrath J.A., Fallin M.D., Liang K.Y., Nestadt G., Feng N., Steel G., Cutting A.S., et al. Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am. J. Hum. Genet. 2009, 84:21-34.
11. Curley A.A., Lewis D.A. Cortical basket cell dysfunction in schizophrenia. J.Physiol. 2012, 590:715-724.
12. Curley A.A., Arion D., Volk D.W., Asafu-Adjei J.K., Sampson A.R., Fish K.N., Lewis D.A. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am. J. Psychiatry 2011, 168:921-929.
13. Di Lazzaro V., Oliviero A., Profice P., Pennisi M.A., Pilato F., Zito G., Dileone M., Nicoletti R., Pasqualetti P., Tonali P.A. Ketamine increases human motor cortex excitability to transcranial magnetic stimulation. J.Physiol. 2003, 547:485-496.
14. Duncan C.E., Webster M.J., Rothmond D.A., Bahn S., Elashoff M., Shannon Weickert C. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J.Psychiatr. Res. 2010, 44:673-681.
15. Fazzari P., Paternain A.V., Valiente M., Pla R., Luján R., Lloyd K., Lerma J., Marín O., Rico B. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 2010, 464:1376-1380.
16. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., Marín O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004, 44:251-261.
17. Flames N., Pla R., Gelman D.M., Rubenstein J.L., Puelles L., Marín O. Delineation of multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes. J.Neurosci. 2007, 27:9682-9695.
18. Fogarty M., Grist M., Gelman D., Marín O., Pachnis V., Kessaris N. Spatial genetic patterning of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex. J.Neurosci. 2007, 27:10935-10946.
19. Ford J.M., Mathalon D.H., Whitfield S., Faustman W.O., Roth W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol. Psychiatry 2002, 51:485-492.
20. Garcia R.A., Vasudevan K., Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc. Natl. Acad. Sci. USA 2000, 97:3596-3601.
21. Gelman D., Griveau A., Dehorter N., Teissier A., Varela C., Pla R., Pierani A., Marín O. A wide diversity of cortical GABAergic interneurons derives from the embryonic preoptic area. J.Neurosci. 2011, 31:16570-16580.
22. Glausier J.R., Lewis D.A. Dendritic spine pathology in schizophrenia. Neuroscience 2012, Published online April 27, 2012. 10.1016/j.neuroscience.2012.04.044.
23. Goldberg E.M., Clark B.D., Zagha E., Nahmani M., Erisir A., Rudy B. K+ channels at the axon initial segment dampen near-threshold excitability of neocortical fast-spiking GABAergic interneurons. Neuron 2008, 58:387-400.
24. Goldberg E.M., Jeong H.Y., Kruglikov I., Tremblay R., Lazarenko R.M., Rudy B. Rapid developmental maturation of neocortical FS cell intrinsic excitability. Cereb. Cortex 2011, 21:666-682.
25. Golub M.S., Germann S.L., Lloyd K.C. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav. Brain Res. 2004, 153:159-170.
26. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch. Gen. Psychiatry 2000, 57:1061-1069.
27. Haenschel C., Bittner R.A., Waltz J., Haertling F., Wibral M., Singer W., Linden D.E., Rodriguez E. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J.Neurosci. 2009, 29:9481-9489.
28. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol. Psychiatry 2006, 60:132-140.
29. Hashimoto T., Volk D.W., Eggan S.M., Mirnics K., Pierri J.N., Sun Z., Sampson A.R., Lewis D.A. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J.Neurosci. 2003, 23:6315-6326.
30. Hashimoto T., Arion D., Unger T., Maldonado-Avilés J.G., Morris H.M., Volk D.W., Mirnics K., Lewis D.A. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol. Psychiatry 2008, 13:147-161.
31. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1998, 1:318-323.
32. Hirano S., Hirano Y., Maekawa T., Obayashi C., Oribe N., Kuroki T., Kanba S., Onitsuka T. Abnormal neural oscillatory activity to speech sounds in schizophrenia: a magnetoencephalography study. J.Neurosci. 2008, 28:4897-4903.
33. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J.Neurosci. 2007, 27:11496-11500.
34. Huang Z.J., Kirkwood A., Pizzorusso T., Porciatti V., Morales B., Bear M.F., Maffei L., Tonegawa S. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 1999, 98:739-755.
35. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., Mei L. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26:443-455.
36. Inda M.C., DeFelipe J., Muñoz A. Morphology and distribution of chandelier cell axon terminals in the mouse cerebral cortex and claustroamygdaloid complex. Cereb. Cortex 2009, 19:41-54.
37. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
38. Jensen O., Kaiser J., Lachaux J.P. Human gamma-frequency oscillations associated with attention and memory. Trends Neurosci. 2007, 30:317-324.
39. Kao W.T., Wang Y., Kleinman J.E., Lipska B.K., Hyde T.M., Weinberger D.R., Law A.J. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc. Natl. Acad. Sci. USA 2010, 107:15619-15624.
40. Kikuchi M., Hashimoto T., Nagasawa T., Hirosawa T., Minabe Y., Yoshimura M., Strik W., Dierks T., Koenig T. Frontal areas contribute to reduced global coordination of resting-state gamma activities in drug-naïve patients with schizophrenia. Schizophr. Res. 2011, 130:187-194.
41. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
42. Lavdas A.A., Grigoriou M., Pachnis V., Parnavelas J.G. The medial ganglionic eminence gives rise to a population of early neurons in the developing cerebral cortex. J.Neurosci. 1999, 19:7881-7888.
43. Lawrie S.M., Buechel C., Whalley H.C., Frith C.D., Friston K.J., Johnstone E.C. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol. Psychiatry 2002, 51:1008-1011.
44. Lewis D.A. The chandelier neuron in schizophrenia. Dev. Neurobiol. 2011, 71:118-127.
45. Lewis D.A., Sweet R.A. Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies. J.Clin. Invest. 2009, 119:706-716.
46. Lewis D.A., Cruz D.A., Melchitzky D.S., Pierri J.N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 2001, 158:1411-1422.
47. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6:312-324.
48. Li K.X., Lu Y.M., Xu Z.H., Zhang J., Zhu J.M., Zhang J.M., Cao S.X., Chen X.J., Chen Z., Luo J.H., et al. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy. Nat. Neurosci. 2012, 15:267-273.
49. Lisman J.E., Coyle J.T., Green R.W., Javitt D.C., Benes F.M., Heckers S., Grace A.A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008, 31:234-242.
50. Loh M., Rolls E.T., Deco G. A dynamical systems hypothesis of schizophrenia. PLoS Comput. Biol. 2007, 3:e228.
51. Loup F., Weinmann O., Yonekawa Y., Aguzzi A., Wieser H.G., Fritschy J.M. A highly sensitive immunofluorescence procedure for analyzing the subcellular distribution of GABAA receptor subunits in the human brain. J.Histochem. Cytochem. 1998, 46:1129-1139.
52. Luykx J.J., Vinkers C.H., Bakker S.C., Visser W.F., van Boxmeer L., Strengman E., van Eijk K.R., Lens J.A., Borgdorff P., Keijzers P., et al. A common variant in ERBB4 regulates GABA concentrations in human cerebrospinal fluid. Neuropsychopharmacology 2012, 37:2088-2092.
53. Marenco S., Geramita M., van der Veen J.W., Barnett A.S., Kolachana B., Shen J., Weinberger D.R., Law A.J. Genetic association of ErbB4 and human cortical GABA levels invivo. J.Neurosci. 2011, 31:11628-11632.
54. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat. Rev. Neurosci. 2008, 9:437-452.
55. Meyer-Lindenberg A.S., Olsen R.K., Kohn P.D., Brown T., Egan M.F., Weinberger D.R., Berman K.F. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch. Gen. Psychiatry 2005, 62:379-386.
56. Minzenberg M.J., Carter C.S. Developing treatments for impaired cognition in schizophrenia. Trends Cogn. Sci. 2012, 16:35-42.
57. Moghaddam B., Krystal J.H. Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr. Bull. 2012, 38:942-949.
58. Morar B., Dragović M., Waters F.A., Chandler D., Kalaydjieva L., Jablensky A. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol. Psychiatry 2011, 16:860-866.
59. Mulle J.G. Schizophrenia genetics: progress, at last. Curr. Opin. Genet. Dev. 2012, 22:238-244.
60. Neddens J., Buonanno A. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 2010, 20:724-744.
61. Neddens J., Fish K.N., Tricoire L., Vullhorst D., Shamir A., Chung W., Lewis D.A., McBain C.J., Buonanno A. Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol. Psychiatry 2011, 70:636-645.
62. Nicodemus K.K., Luna A., Vakkalanka R., Goldberg T., Egan M., Straub R.E., Weinberger D.R. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol. Psychiatry 2006, 11:1062-1065.
63. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., Williams H.J., Preece A.C., Dwyer S., Wilkinson J.C., et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141B:96-101.
64. Nusser Z., Sieghart W., Benke D., Fritschy J.M., Somogyi P. Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells. Proc. Natl. Acad. Sci. USA 1996, 93:11939-11944.
65. Pratt J., Winchester C., Dawson N., Morris B. Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap. Nat. Rev. Drug Discov. 2012, 11:560-579.
66. Rico B., Marín O. Neuregulin signaling, cortical circuitry development and schizophrenia. Curr. Opin. Genet. Dev. 2011, 21:262-270.
67. Rymar V.V., Sadikot A.F. Laminar fate of cortical GABAergic interneurons is dependent on both birthdate and phenotype. J.Comp. Neurol. 2007, 501:369-380.
68. Shamir A., Kwon O.B., Karavanova I., Vullhorst D., Leiva-Salcedo E., Janssen M.J., Buonanno A. The importance of the NRG-1/ErbB4 pathway for synaptic plasticity and behaviors associated with psychiatric disorders. J.Neurosci. 2012, 32:2988-2997.
69. Sigurdsson T., Stark K.L., Karayiorgou M., Gogos J.A., Gordon J.A. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature 2010, 464:763-767.
70. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2006, 141B:142-148.
71. Sohal V.S., Zhang F., Yizhar O., Deisseroth K. Parvalbumin neurons and gamma rhythms enhance cortical circuit performance. Nature 2009, 459:698-702.
72. Sousa V.H., Miyoshi G., Hjerling-Leffler J., Karayannis T., Fishell G. Characterization of Nkx6-2-derived neocortical interneuron lineages. Cereb. Cortex 2009, 19(Suppl 1):i1-i10.
73. Spencer K.M. Baseline gamma power during auditory steady-state stimulation in schizophrenia. Front. Hum. Neurosci. 2011, 5:190.
74. Spencer K.M., Nestor P.G., Niznikiewicz M.A., Salisbury D.F., Shenton M.E., McCarley R.W. Abnormal neural synchrony in schizophrenia. J.Neurosci. 2003, 23:7407-7411.
75. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71:877-892.
76. Sullivan E.M., O'Donnell P. Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophr. Bull. 2012, 38:373-376.
77. Sullivan P.F., Daly M.J., O'Donovan M. Genetic architectures ofpsychiatric disorders: the emerging picture and its implications. Nat. Rev. Genet. 2012, 13:537-551.
78. Suzuki Y., Jodo E., Takeuchi S., Niwa S., Kayama Y. Acute administration of phencyclidine induces tonic activation of medial prefrontal cortex neurons in freely moving rats. Neuroscience 2002, 114:769-779.
79. Ting A.K., Chen Y., Wen L., Yin D.M., Shen C., Tao Y., Liu X., Xiong W.C., Mei L. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J.Neurosci. 2011, 31:15-25.
80. Uhlhaas P.J., Singer W. Neuronal dynamics and neuropsychiatric disorders: toward a translational paradigm for dysfunctional large-scale networks. Neuron 2012, 75:963-980.
81. Uhlhaas P.J., Linden D.E., Singer W., Haenschel C., Lindner M., Maurer K., Rodriguez E. Dysfunctional long-range coordination of neural activity during Gestalt perception in schizophrenia. J.Neurosci. 2006, 26:8168-8175.
82. Volk D.W., Austin M.C., Pierri J.N., Sampson A.R., Lewis D.A. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 2000, 57:237-245.
83. Volk D.W., Pierri J.N., Fritschy J.M., Auh S., Sampson A.R., Lewis D.A. Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb. Cortex 2002, 12:1063-1070.
84. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
85. Wang X.J., Buzsáki G. Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model. J.Neurosci. 1996, 16:6402-6413.
86. Wang Y.C., Chen J.Y., Chen M.L., Chen C.H., Lai I.C., Chen T.T., Hong C.J., Tsai S.J., Liou Y.J. Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol. Psychiatry 2008, 64:1093-1096.
87. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., Yin D.M., Lai C., Terry A.V., Vazdarjanova A., et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc. Natl. Acad. Sci. USA 2010, 107:1211-1216.
88. Woo T.U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl. Acad. Sci. USA 1998, 95:5341-5346.
89. Woo R.S., Li X.M., Tao Y., Carpenter-Hyland E., Huang Y.Z., Weber J., Neiswender H., Dong X.P., Wu J., Gassmann M., et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007, 54:599-610.
90. Yau H.J., Wang H.F., Lai C., Liu F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb. Cortex 2003, 13:252-264.
91. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson T.J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.